133 related articles for article (PubMed ID: 8680672)
1. The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis.
Hordvik NL; Sammut PH; Judy CG; Strizek SJ; Colombo JL
Am J Respir Crit Care Med; 1996 Jul; 154(1):156-60. PubMed ID: 8680672
[TBL] [Abstract][Full Text] [Related]
2. Effects of standard and high doses of salmeterol on lung function of hospitalized patients with cystic fibrosis.
Hordvik NL; Sammut PH; Judy CG; Colombo JL
Pediatr Pulmonol; 1999 Jan; 27(1):43-53. PubMed ID: 10023791
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
Hordvik NL; Sammut PH; Judy CG; Colombo JL
Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
Elkins MR; Robinson M; Rose BR; Harbour C; Moriarty CP; Marks GB; Belousova EG; Xuan W; Bye PT;
N Engl J Med; 2006 Jan; 354(3):229-40. PubMed ID: 16421364
[TBL] [Abstract][Full Text] [Related]
5. Effect of albuterol on maximal exercise capacity in cystic fibrosis.
Serisier DJ; Coates AD; Bowler SD
Chest; 2007 Apr; 131(4):1181-7. PubMed ID: 17426226
[TBL] [Abstract][Full Text] [Related]
6. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
7. Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report.
König P; Gayer D; Barbero GJ; Shaffer J
Pediatr Pulmonol; 1995 Oct; 20(4):205-14. PubMed ID: 8606849
[TBL] [Abstract][Full Text] [Related]
8. Clinical comparison of albuterol, isoetharine, and metaproterenol given by aerosol inhalation.
Berezuk GP; Schondelmeyer SW; Seidenfeld JJ; Jones WN; Bootman JL
Clin Pharm; 1983; 2(2):129-34. PubMed ID: 6349905
[TBL] [Abstract][Full Text] [Related]
9. The effect of tiotropium on the pulmonary diffusing capacity.
Gonlugur U
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
[TBL] [Abstract][Full Text] [Related]
10. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
11. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
Regelmann WE; Elliott GR; Warwick WJ; Clawson CC
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):914-21. PubMed ID: 2109558
[TBL] [Abstract][Full Text] [Related]
12. Effect of salbutamol on gas compression in cystic fibrosis and asthma.
Desmond KJ; Demizio DL; Allen PD; MacDonald ND; Coates AL
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):673-7. PubMed ID: 8118635
[TBL] [Abstract][Full Text] [Related]
13. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis.
König P; Poehler J; Barbero GJ
Pediatr Pulmonol; 1998 Jan; 25(1):32-6. PubMed ID: 9475328
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma.
Spector SL; Nicodemus CF; Corren J; Schanker HM; Rachelefsky GS; Katz RM; Siegel SC
J Allergy Clin Immunol; 1995 Aug; 96(2):174-81. PubMed ID: 7636054
[TBL] [Abstract][Full Text] [Related]
16. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
Dodd JD; Barry SC; Daly LE; Gallagher CG
J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose ibuprofen in patients with cystic fibrosis.
Konstan MW; Byard PJ; Hoppel CL; Davis PB
N Engl J Med; 1995 Mar; 332(13):848-54. PubMed ID: 7503838
[TBL] [Abstract][Full Text] [Related]
18. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
[TBL] [Abstract][Full Text] [Related]
19. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
20. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]